Kaisha Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 9.80 Cr
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 16.41 Cr
- Revenue Growth -33.51%
- Profit Growth 480.94%
- Ebitda -232.52%
- Net Worth 639.09%
- Total Assets -22.93%
About Kaisha Lifesciences
Kaisha Lifesciences Private Limited (KLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 July 2010 and has a history of 14 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Sovereignty Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.80 Cr.
The company currently has active open charges totaling ₹16.41 Cr.
Rishad Dadachanji, Sangeeta Rivankar, and Kairus Dadachanji serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74120MH2010PTC205291
- Company No.
205291
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jul 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Kaisha Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rishad Dadachanji  | Managing Director | 28-May-2014 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sangeeta Rivankar | Whole-Time Director | 05-Jun-2024 | Current |
| Kairus Dadachanji | Director | 22-Sep-2022 | Current |
Financial Performance of Kaisha Lifesciences.
Kaisha Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.51% decrease. The company also saw a substantial improvement in profitability, with a 480.94% increase in profit. The company's net worth Soared by an impressive increase of 639.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kaisha Lifesciences?
In 2023, Kaisha Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sovereign Pharma Private LimitedRishad Dadachanji and Kairus Dadachanji are mutual person
Kaisha Packaging Private LimitedRishad Dadachanji and Kairus Dadachanji are mutual person
Schott Poonawalla Private LimitedKairus Dadachanji is a mutual person
Kairish Innotech Private LimitedRishad Dadachanji and Kairus Dadachanji are mutual person
Kairish Shared Services LlpRishad Dadachanji and Kairus Dadachanji are mutual person
- Kairish Real Estate Llp
Rishad Dadachanji and Kairus Dadachanji are mutual person
Charges (Loans)
₹16.41 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 16.41 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Oct 2024 | Others | ₹1.05 M | Open |
| 03 Nov 2022 | Others | ₹1.50 M | Open |
| 03 Nov 2022 | Others | ₹1.50 M | Open |
| 02 Dec 2021 | Others | ₹8.00 Cr | Open |
| 30 Nov 2021 | Others | ₹8.00 Cr | Open |
How Many Employees Work at Kaisha Lifesciences?
Kaisha Lifesciences has a workforce of 40 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kaisha Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaisha Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
